Evaluation of molecular mechanism differences in in vitro models of drug induced and fatty- acids induced NAFLD (CROSBI ID 650396)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Omanović, Tea ; Kizivat, Tomislav ; Raguž- Lučić, Nikola ; Ninčević, Vjera ; Jakab, Jelena ; Kuna, Lucija ; Smolić, Robert ; Bilić-Čurčić, Ines ; Včev, Aleksandar ; Smolić, Martina
engleski
Evaluation of molecular mechanism differences in in vitro models of drug induced and fatty- acids induced NAFLD
Throughout the last decades, prevalence of NAFLD (non-alcoholic fatty liver disease) is dramatically increasing. NAFLD includes a spectrum of disorders such as steatosis, non- alcoholic steatohepatitis and fibrosis/cirrhosis. It is estimated that approximately 20% of adult population has hepatic steatosis and 2-3% suffer from non- alcoholic steatohepatitis. Previously, numerous drugs had been proven to cause fatty liver disease, however molecular mechanisms of drug induced NAFLD are not fully elucidated. Therefore, the aim of our study was to evaluate molecular mechanisms involved in development of drug-induced fatty liver disease and fatty-acid induced NAFLD in vitro. FAs and hepatotoxic drugs had lipogenic effect on triglyceride accumulation and steatogenesis in hepatocyte cell cultures. This steatogenic effect was characterized by differences in excessive accumulation of trilycerides together with the appearance of Oil Red O–stained lipid vesicles and overexpression of genes involved in lipogenesis and droplet formation.
NAFLD ; cell culture ; fatty acids
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
83-83.
2017.
objavljeno
Podaci o matičnoj publikaciji
The 1st International Conference on Fatty Liver Abstracts
Safadi, Rifaat ; Sanyal, Arun ; Anstee, Quentin
Basel: Karger Publishers
Podaci o skupu
The 1st International Conference on Fatty Liver
poster
01.06.2017-03.06.2017
Sevilla, Španjolska